Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T4LIFE trial of levothyroxine in euthyroid women with recurrent miscarriage and positive TPO antibodies
NL-OMON44997Phase 3Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in recurrent miscarriage (RPL) and autoimmune thyroid disease (AITD) comparing Levothyroxine with Placebo (2 arms). Primary endpoint: live birth rate. Started Jan 2013; status: active, not recruiting.
02
Drugs
levothyroxine sodium
03
Conditions
recurrent miscarriage (RPL)autoimmune thyroid disease (AITD)
Beyond the preview
Go deeper on NL-OMON44997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44997.